Gerald Maguire
Psychiatry · San Juan Capistraco, CANPI 1144300302
Payments from drug & device makers
$6,602,652in general payments, 2019–2025
Across 2,253 payments — averaging $2930.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$1.7M
- Teva Pharmaceuticals USA, Inc.$1.1M
- AbbVie$1M
- Otsuka Pharmaceutical Development & Commercialization, Inc.$561K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$356K
- Neurocrine Biosciences, Inc.$336K
- plus $1.6M from 21 others
General payments by program year
19
20
21
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 207 | $1,702,579 |
| Teva Pharmaceuticals USA, Inc. | 48 | $1,054,978 |
| AbbVie(2 entities) | 55 | $1,032,624 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 16 | $560,870 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 232 | $355,715 |
| Neurocrine Biosciences, Inc. | 367 | $336,325 |
| Alkermes, Inc. | 283 | $289,712 |
| Otsuka America Pharmaceutical, Inc. | 324 | $261,006 |
| Sumitomo Pharma America, Inc. | 42 | $180,746 |
| Axsome Therapeutics, Inc. | 162 | $173,623 |
| Boehringer Ingelheim | 22 | $133,127 |
| Janssen Research & Development, LLC | 28 | $132,760 |
| Vanda Pharmaceuticals Inc. | 95 | $107,853 |
| Johnson & Johnson | 166 | $98,289 |
| Sunovion Pharmaceuticals Inc. | 125 | $67,012 |
| Supernus Pharmaceuticals, Inc. | 6 | $60,964 |
| F. Hoffmann-la Roche AG | 5 | $14,000 |
| Acadia Pharmaceuticals Inc | 13 | $9,811 |
| Eisai Inc. | 5 | $8,385 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $6,068 |
| Bioxcel Therapeutics, Inc. | 1 | $5,700 |
| Boehringer Ingelheim International GmbH | 33 | $5,216 |
| Sage Therapeutics, LLC | 4 | $2,818 |
| Merck | 1 | $2,292 |
| Biogen | 1 | $102 |
| Indivior Inc. | 2 | $42 |
| Novartis | 1 | $36 |
How this compares
$6,602,652 in reported general payments places this provider in the 95th percentile of 4,954 psychiatry providers in California.
Other psychiatry in San Juan Capistraco
- Elly LeeIrvine$49.8M
- Daniel ChuehOrange$17.9M
- Eric ChavezSan Diego$15.5M
- Lara ShirikjianTorrance$12.6M
- John DuffySanta Ana$12M
- Marina BusselPlaya Vista$12M
- Sherry SoefjeOceanside$11.9M
- Steven MacinaHuntington Beach$11.1M
- Wakelin McNeelRosemead$11M
- Donald AndersonBanning$10.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.